Parkside Financial Bank & Trust
BankPosition in GILD — Gilead Sciences, Inc.
CIK 1455267
SAINT LOUIS, MO
Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$582,147
+$62,958 QoQ
Shares Held
4,177
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $28,780,130 across 15 Drug Manufacturers - General names. GILD ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,749 | $7,127,297 | |
| 2 | ABBV |
AbbVie Inc.
|
28,631 | $6,226,955 | |
| 3 | JNJ |
Johnson & Johnson
|
20,434 | $4,994,886 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,825 | $3,106,488 | |
| 5 | PFE |
Pfizer Inc
|
72,976 | $2,049,165 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,005 | $1,637,853 | |
| 7 | AMGN |
Amgen Inc
|
3,990 | $1,403,881 | |
| 8 | NVS |
Novartis AG
|
5,576 | $851,733 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $582,147 | 4,177 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $519,189 | 4,230 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $456,876 | 4,116 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $434,166 | 3,916 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $349,707 | 3,121 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $277,756 | 3,007 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $233,912 | 2,790 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $181,130 | 2,640 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $239,380 | 3,268 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $248,133 | 3,063 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $217,175 | 2,898 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $208,088 | 2,700 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $159,800 | 1,926 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $156,675 | 1,825 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $104,070 | 1,687 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $82,515 | 1,335 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $44,409 | 747 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $95,191 | 1,311 | Shares | Defined | 2022-03-01 | |
| 2021-09-30 | $105,613 | 1,512 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $85,179 | 1,237 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $69,282 | 1,072 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $105,858 | 1,817 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $145,083 | 2,296 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $188,733 | 2,453 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $190,039 | 2,542 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||